NCT03724292 An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03721172 Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy Status COMPLETED Phase PHASE3
NCT03718884 A Study of Mirikizumab in Participants With Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT03718299 A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis Status COMPLETED Phase PHASE4
NCT03706209 Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT03701763 Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03662685 Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris Status TERMINATED Phase PHASE1
NCT03661866 A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03656627 Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease Status TERMINATED Phase PHASE1
NCT03635099 This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is Status COMPLETED Phase PHASE2
NCT03629379 Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions Status COMPLETED Phase PHASE4
NCT03626714 Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study Status COMPLETED Phase EARLY_PHASE1
NCT03624127 Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis Status COMPLETED Phase PHASE3
NCT03611751 An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03597620 Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis Status COMPLETED Phase PHASE4
NCT03594877 Effect of Sublimated Mare Milk Supplement on Gut Microbiome in Psoriasis Patients Status COMPLETED Phase NA
NCT03587194 Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis Status COMPLETED Phase PHASE4
NCT03580278 A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2 Status COMPLETED Phase PHASE1